D10000: "INTERNATIONAL DRUG DEVELOPMENT INSTITUTE"
DM0000: The mark consists of the letters and name as shown which may be displayed in black and white or with Navvy letters for the symbol, red letters for the full spelling and the ball in the center colored red.
GS0421: Research and consultation services in the field of clinical trials for drug development, including the areas of clinical operations, data management, biostatistics, clinical systems, clinical development strategies, experimental design, clinical trial methodology, clinical research in oncology and other therapeutic areas, and epistemology
Case File Event Statements
3/4/2011 - 14 years ago
14 - CANCELLED SEC. 8 (6-YR)Type:C8..
12/1/2009 - 15 years ago
13 - CASE FILE IN TICRSType:CFIT
8/3/2004 - 21 years ago
12 - REGISTERED-PRINCIPAL REGISTERType:R.PR
5/11/2004 - 21 years ago
11 - PUBLISHED FOR OPPOSITIONType:PUBO
4/21/2004 - 21 years ago
10 - NOTICE OF PUBLICATIONType:NPUB
3/2/2004 - 21 years ago
9 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
9/8/2003 - 22 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
9/8/2003 - 22 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
4/2/2003 - 22 years ago
6 - FINAL REFUSAL E-MAILEDType:GNFR
2/26/2003 - 22 years ago
5 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
2/26/2003 - 22 years ago
4 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
2/26/2003 - 22 years ago
3 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA